Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Nathan

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 1997
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapyF E Nathan, D Berd, T Sato, et al.
Pediatric Hematology and Oncology|May 1, 1994
Anti-Bak(a) neonatal alloimmune thrombocytopenia: possible prevention by intravenous immunoglobulinF E Nathan, J H Herman, M Keashen-Schnell, et al.
Cancer|October 3, 2000
Protracted survival after resection of metastatic uveal melanomaT Aoyama, M J Mastrangelo, D Berd, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancerK Miller, J W Moul, M Gleave, et al.
ESMO Open|February 14, 2022
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patientsK J O'Byrne, K H Lee, S-W Kim, et al.
ESMO Open|November 21, 2023
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trialH Borghaei, K J O'Byrne, L Paz-Ares, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 1997
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapyF E Nathan, D Berd, T Sato, et al.
Pediatric Hematology and Oncology|May 1, 1994
Anti-Bak(a) neonatal alloimmune thrombocytopenia: possible prevention by intravenous immunoglobulinF E Nathan, J H Herman, M Keashen-Schnell, et al.
Cancer|October 3, 2000
Protracted survival after resection of metastatic uveal melanomaT Aoyama, M J Mastrangelo, D Berd, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancerK Miller, J W Moul, M Gleave, et al.
ESMO Open|February 14, 2022
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patientsK J O'Byrne, K H Lee, S-W Kim, et al.
ESMO Open|November 21, 2023
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trialH Borghaei, K J O'Byrne, L Paz-Ares, et al.
Pageof 2